Home > Newsletters > Drug Industry Daily > FDA Lacks Policy to Deal With EU Falsified Medicines Directive, Shortage Concern Looms
Drug Industry Daily
Nov. 6, 2012 | Vol. 11 No. 218
FDA Lacks Policy to Deal With EU Falsified Medicines Directive, Shortage Concern Looms
The FDA’s lack of a policy or guidance to help API manufacturers deal with a new European directive is causing concern among manufacturers about lost sales and drug shortages in Europe, an expert says.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.